RxDoctor Payments Data

Lada Sloan, MD

Geriatric Medicine · Nashville, TNNPI 1336377837

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Hologic Sales And Service, LLC at 28.5% of the total. That places this record below the midpoint for geriatric medicine clinicians in TN, where the typical reported total is $207.

$163in general payments, 2019–2025

Across 8 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hologic Sales And Service, LLC$46
  • Novo Nordisk$24
  • Lundbeck LLC$21
  • Merck$21
  • Astellas Pharma US Inc$20
  • Exact Sciences$17
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$163100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$163 in reported general payments places this provider in the 45th percentile of 46 geriatric medicine providers in Tennessee.

See all geriatric medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$114,359
Medicare patients
315
Services billed
2,776

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide314$416,085
EliquisApixaban213$217,222
TrulicityDulaglutide69$85,247
JardianceEmpagliflozin72$71,712
JanuviaSitagliptin Phosphate48$53,888
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$45,737
XareltoRivaroxaban53$42,935
Spiriva RespimatTiotropium Bromide69$38,797
MyrbetriqMirabegron41$33,214
FarxigaDapagliflozin Propanediol23$29,833
Repatha SureclickEvolocumab42$29,160
RybelsusSemaglutide19$26,756
MounjaroTirzepatide22$25,404
LinzessLinaclotide18$23,889
ViberziEluxadoline13$20,921

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$24$442,841333 claims
PfizerEliquis, Premarin$13$221,312227 claims
MerckJanuvia, Janumet Xr$21$66,08763 claims
Astellas Pharma US IncMyrbetriq$20$33,21441 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 46 geriatric medicine providers in Tennessee.

Other geriatric medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →